Estrogen-only hormone therapy linked to lower dementia risk

A recent study published in the medical journal Neurology has shed light on the potential benefits of hormone therapy for older adults. The research, which involved analyzing data from over 1,000 women, found a significant association between the use of hormone therapy later in life and a lower risk of developing dementia. This finding is particularly noteworthy given the growing concern over age-related cognitive decline and the search for effective preventive measures.

According to the study, women who initiated hormone therapy at an average age of 65 or older experienced a reduced risk of dementia compared to those who did not receive hormone therapy. The researchers attributed this protective effect to the potential neuroprotective properties of hormones, such as estrogen, which have been shown to promote brain health and cognitive function. The study's findings suggest that hormone therapy may be a viable option for older adults seeking to mitigate their risk of dementia, although more research is needed to confirm these results.

While the study's findings are intriguing, they also underscore the need for further investigation into the long-term effects of hormone therapy on brain health. The researchers emphasize that hormone therapy should only be initiated under the guidance of a healthcare professional, as it carries potential risks and side effects, particularly for women with a history of certain medical conditions. As the global population ages, the discovery of effective preventive strategies for dementia is a pressing concern, and this study's findings offer a promising area of exploration.